Načítá se...

Second‐Line Treatment Landscape for Renal Cell Carcinoma: A Comprehensive Review

The management of advanced clear‐cell renal cell carcinoma has steadily improved over the past decade with the introduction of antiangiogenic and targeted therapies. Recently, three new therapies have been approved for use as second‐line options that further advance the treatment armamentarium: nivo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncologist
Hlavní autoři: Tannir, Nizar M., Pal, Sumanta K., Atkins, Michael B.
Médium: Artigo
Jazyk:Inglês
Vydáno: AlphaMed Press 2018
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5947457/
https://ncbi.nlm.nih.gov/pubmed/29487224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0534
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!